[Acute coronary angiography in therapy-refractory angina pectoris]. 1986

U Tebbe, and G Sauer, and H Kreuzer, and A Vogt, and K P Bethge, and V Wiegand, and K L Neuhaus

Emergency coronary angiography was performed in 188 patients with treatment-resistant unstable angina. Criteria analysed were: duration of angina less than 72 h; angina despite heparin and nitroglycerin infusion; no significant S-T segment elevation in the ECG; creatine-kinase rise up to 150 U/l. Coronary heart disease (CHD) was found in 130 patients (group A). In 47 of them a recent coronary occlusion was demonstrated angiographically (main stem: 1; anterior interventricular branch: 8; circumflex branch: 27; right coronary artery: 11 patients). An at least 90% occlusion of one coronary artery was found in 58 patients. A 75% stenosis of several vessels was found in 25 patients making it impossible to identify the vessel that had caused the angina. A bypass operation was performed in 62 patients within two weeks. During the acute coronary angiography, intracoronary streptokinase infusion was performed in 11 (success rate 55%), percutaneous transluminal coronary angioplasty in 26 (success rate 88%). In 58 patients (group B) CHD was excluded. The final diagnosis in these was: mitral valve prolapse (31); pericarditis (6), dilated cardiomyopathy (3); coronary anomaly (3); muscle bridge in the anterior interventricular branch (2): normal (13). CONCLUSIONS It is not possible to decide with certainty, in the absence of typical infarction signs in the ECG and clinically, whether treatment-resistant angina is due to CHD or other causes. Acute coronary angiography is indicated in such cases, because even without S-T segment elevation an acute coronary occlusion is present in 25%, and in 50% of cases an acute therapeutic intervention is indicated.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D004630 Emergencies Situations or conditions requiring immediate intervention to avoid serious adverse results. Emergency
D005260 Female Females
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

U Tebbe, and G Sauer, and H Kreuzer, and A Vogt, and K P Bethge, and V Wiegand, and K L Neuhaus
August 1994, Nihon rinsho. Japanese journal of clinical medicine,
U Tebbe, and G Sauer, and H Kreuzer, and A Vogt, and K P Bethge, and V Wiegand, and K L Neuhaus
November 1970, Acta medica Scandinavica,
U Tebbe, and G Sauer, and H Kreuzer, and A Vogt, and K P Bethge, and V Wiegand, and K L Neuhaus
April 1971, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
U Tebbe, and G Sauer, and H Kreuzer, and A Vogt, and K P Bethge, and V Wiegand, and K L Neuhaus
October 1961, Acta chirurgica Scandinavica,
U Tebbe, and G Sauer, and H Kreuzer, and A Vogt, and K P Bethge, and V Wiegand, and K L Neuhaus
June 1981, Schweizerische medizinische Wochenschrift,
U Tebbe, and G Sauer, and H Kreuzer, and A Vogt, and K P Bethge, and V Wiegand, and K L Neuhaus
January 2011, International anesthesiology clinics,
U Tebbe, and G Sauer, and H Kreuzer, and A Vogt, and K P Bethge, and V Wiegand, and K L Neuhaus
April 1997, Acta medica portuguesa,
U Tebbe, and G Sauer, and H Kreuzer, and A Vogt, and K P Bethge, and V Wiegand, and K L Neuhaus
April 1979, British medical journal,
U Tebbe, and G Sauer, and H Kreuzer, and A Vogt, and K P Bethge, and V Wiegand, and K L Neuhaus
May 2012, MMW Fortschritte der Medizin,
U Tebbe, and G Sauer, and H Kreuzer, and A Vogt, and K P Bethge, and V Wiegand, and K L Neuhaus
January 1992, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!